Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > What's the scoop with Ate
View:
Post by Canadian_101 on Dec 10, 2020 3:46pm

What's the scoop with Ate

Why is the stock price stuck in the mud for ATE, they went to the TSX and basically nothing has happened as far as I can tell, why has it dropped so much and why is it staying at the price it is at. 

 Should I sell and take the tax loss or hold,  if hold can you tell me why??

Whats everyones thoughts???
Comment by IrishCanuck on Dec 10, 2020 3:53pm
Yes please sell me your shares
Comment by Forestview on Dec 10, 2020 4:19pm
These are all strategic moves that are prepping the stage for some news.  So, selling now may be a poor idea.  They've increased the size of the audience, so that when something drops (that's positive), the demand will be greater, therefore driving up the price. Selling now based on these strategic moves that were never really meant to drive up the price may be premature. I' ...more  
Comment by MrMugsy on Dec 10, 2020 4:41pm
It doesn't seem foolish ... I think all investors, even the future institutional investors will agree that we are severely undervalued.  Sure hope so.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities